Cyproterone acetate is a potent anti-androgen and synthetic progestin medication used to treat androgen-dependent conditions, including advanced prostate cancer, severe acne, hirsutism, and hypersexuality.Common side effects include reduced sex drive, erectile dysfunction, fatigue, weight changes, hot flashes, and breast tenderness or enlargement.Serious but less common risks include severe liver toxicity, blood clots (thromboembolism), depression, and the development of meningiomas (benign brain tumors) with long-term high-dose use.
What is Cyproterone Acetate?
Cyproterone acetate is a synthetic steroid derivative that functions primarily as an anti-androgen and progestin. By competing with natural male sex hormones (androgens) such as testosterone and dihydrotestosterone (DHT) at the androgen receptor site, it blocks their biological action in target tissues. Additionally, its progestogenic action exerts a negative feedback effect on the pituitary gland, suppressing the release of luteinising hormone (LH) and subsequently lowering serum testosterone levels.
This dual mechanism makes cyproterone acetate effective across several clinical indications:
- Prostate Cancer Management:Used in high doses to treat inoperable prostatic carcinoma and to suppress the initial testosterone “flare” associated with LHRH agonist therapy.
- Severe Dermatological Conditions: Prescribed in lower doses (often in combination with ethinylestradiol) for women suffering from severe acne, seborrhea, or hirsutism driven by hyperandrogenism.
- Hypersexuality:Used in adult males to reduce sexual drive and control severe sexual deviations.
- Gender-Affirming Therapy: Prescribed off-label in feminine hormone therapy protocols to suppress testosterone production.
Common Side Effects
Most patients experience mild to moderate side effects, particularly during the initial weeks of treatment as the endocrine system adjusts to reduced androgen activity.
Fatigue and Lethargy
Feeling unusually tired, weak, or lacking energy (lassitude) is a frequently reported side effect during the first few weeks of therapy.This effect tends to diminish after approximately two to three months as the body adapts.Patients are advised to exercise caution when driving or operating machinery if drowsiness occurs.
Sexual and Reproductive Changes
Because cyproterone acetate significantly lowers androgen activity, sexual function is directly affected:
- Decreased Libido:A notable reduction in sexual drive and desire in both men and women.
- Erectile Dysfunction:Men frequently experience difficulty achieving or maintaining an erection.
- Suppression of Spermatogenesis:In men, cyproterone acetate reduces sperm count and ejaculate volume.Azoospermia (absence of motile sperm) can develop after several weeks of continuous therapy.Spermatogenesis generally recovers within 3 to 20 months after discontinuing the medication.
Physical and Hormonal Modifications
- Gynecomastia and Breast Tenderness:Men taking cyproterone acetate may develop breast tissue enlargement (gynecomastia) accompanied by soreness or tenderness.
- Hot Flashes and Sweats: Similar to menopausal symptoms, patients may experience sudden episodes of warmth, facial flushing, and night sweats due to reduced sex steroid levels.
- Weight Alterations:Weight gain is common and may stem from increased fluid retention or metabolic changes.Some patients, conversely, report weight loss.
- Skin and Hair Changes:While cyproterone acetate reduces sebum production and improves facial acne, it can cause dry skin, patchy loss of body hair, or changes in hair growth patterns.
Mood Shifts and Psychological Effects
Fluctuations in mood, emotional instability, and low mood or clinical depression can occur.Patients with a history of severe depression require close monitoring, as pre-existing depressive conditions may worsen during treatment.
Serious Risks and High-Risk Warnings
While common side effects are often manageable, cyproterone acetate carries several critical safety warnings that require strict medical oversight.
Hepatotoxicity (Liver Damage)
Direct liver toxicity—including hepatitis, jaundice, and acute hepatic failure—is one of the most severe potential complications of cyproterone acetate therapy.Cases of fatal liver failure have been reported, primarily in patients taking high daily doses (200 mg to 300 mg) for prostate cancer.Additionally, sex steroids including cyproterone acetate have been associated with benign and, in rare instances, malignant liver tumors that can cause life-threatening intra-abdominal bleeding.
Liver function tests (LFTs) must be conducted prior to starting treatment, at regular monthly intervals during therapy, and whenever potential hepatic symptoms arise.
Thromboembolic Events (Blood Clots)
Cyproterone acetate increases the risk of developing blood clots. This includes:
- Deep Vein Thrombosis (DVT):Clots forming in the deep veins of the legs or arms.
- Pulmonary Embolism (PE): A clot breaking free and traveling to the lungs, blocking pulmonary blood flow.
- Arterial Thrombosis:Increased risk of myocardial infarction (heart attack) or cerebrovascular accident (stroke).
Risk factors such as smoking, obesity, advanced age, prolonged immobilization, and personal or family history of venous thromboembolism significantly compound this danger.
Meningioma Risk
Prolonged use of cyproterone acetate—especially at high daily doses (25 mg or higher)—has been definitively linked to the development of single or multiple meningiomas (benign brain tumors). The risk escalates with cumulative dose exposure over time. If a patient is diagnosed with a meningioma, cyproterone acetate treatment must be immediately and permanently discontinued.
Adrenal Suppression and Metabolic Impacts
At high doses, cyproterone acetate exerts a corticoid-like action that can suppress the hypothalamic-pituitary-adrenal (HPA) axis, reducing the body’s natural cortisol production. Metabolic monitoring is also essential because cyproterone acetate can impair glucose tolerance, raising blood sugar levels in diabetic or pre-diabetic patients.
Dosage-Dependent Side Effect Profiles
The severity and frequency of side effects correlate strongly with the prescribed daily dosage:
| Dosage Level | Common Indications | Primary Side Effect Profile | Key Risk Considerations |
| High Dose (50 mg – 300 mg daily) | Prostate cancer, severe sexual deviations | Severe loss of libido, erectile dysfunction, persistent fatigue, muscle weakness, gynecomastia, hot flashes | High risk of hepatotoxicity, meningioma, thromboembolism, and HPA axis suppression |
| Low Dose (2 mg – 10 mg daily, often combined) | Severe acne, hirsutism, PCOS | Mild breast tenderness, light irregular bleeding, mood swings, mild fatigue, skin dryness | Lower liver risk; VTE risk remains present due to estrogen-progestin synergy |
When to Seek Immediate Medical Attention
Patients taking cyproterone acetate should contact a healthcare provider immediately or seek emergency medical care if any of the following warning signs occur:
- Signs of Liver Dysfunction:Yellowing of the skin or eyes (jaundice), unusually dark urine, pale or light-colored stools, persistent severe pain in the upper right abdomen, unexplained nausea, or loss of appetite.
- Signs of Blood Clots: Sudden pain, swelling, tenderness, or warmth in one leg; acute shortness of breath; sudden chest pain or tightness; coughing up blood.
- Neurological Symptoms (Meningioma Warning Signs):Visual disturbances (blurred or double vision), gradual hearing loss or ringing in the ears, persistent or worsening headaches, loss of smell, memory loss, seizures, or weakness in the arms or legs.
- Severe Allergic Reactions:Hives, severe skin rash, blistering, swelling of the face, lips, tongue, or throat, or difficulty breathing or swallowing.
Precautions and Contraindications
Cyproterone acetate is strictly contraindicated in individuals with:
- Existing or past liver diseases, including hepatic tumors or jaundice
- Existing or history of benign brain tumors (meningioma)
- History or presence of venous or arterial thromboembolic events
- Severe chronic depression
- Severe diabetes mellitus with vascular complications
- Sickle-cell anemia
- Wasting syndromes (except in prostate cancer cases)
- Pregnancy or breastfeeding (causes feminisation of male fetuses and passes into breast milk)
Routine blood tests—including hepatic enzyme panels, blood counts, lipid profiles, and fasting blood glucose—are mandatory throughout the treatment course to ensure patient safety.
Frequently Asked Questions
What are the most common side effects of cyproterone acetate?
The most common side effects include reduced sexual desire (libido), fatigue, difficulty achieving erections in men, weight changes, hot flashes, sweating, depressed mood, and breast swelling or tenderness (gynecomastia).Most mild side effects appear early in treatment and may diminish over time.
Can cyproterone acetate cause permanent infertility?
Cyproterone acetate suppresses sperm production (spermatogenesis) and ejaculate volume in men, which leads to temporary infertility during treatment.In the majority of cases, this effect is fully reversible, with sperm counts returning to pre-treatment levels within 3 to 20 months after stopping the medication. However, recovery times vary depending on dosage and duration of therapy.
Why is liver function monitoring necessary during cyproterone treatment?
Cyproterone acetate is metabolized by the liver and can cause direct liver toxicity, ranging from mild liver enzyme elevations to severe hepatitis, jaundice, and fatal liver failure. Regular liver function tests (LFTs) allow doctors to detect liver strain early and discontinue the drug before irreversible damage occurs.
How does cyproterone acetate affect mood and mental health?
By suppressing testosterone and altering central nervous system hormonal balance, cyproterone acetate can cause mood swings, anxiety, low energy, and clinical depression.Patients with a personal history of depression should be carefully evaluated before starting therapy, and any worsening of mood should be reported to a doctor immediately.
What is the link between cyproterone acetate and brain tumors (meningioma)?
High-dose or prolonged cyproterone acetate therapy has been shown to increase the risk of developing meningiomas—typically non-cancerous tumors of the brain lining. The risk accumulates with higher cumulative doses over time. Because of this risk, cyproterone acetate is contraindicated in patients with a history of meningioma, and treatment must stop permanently if a tumor is detected.
Does cyproterone acetate cause weight gain?
Yes, weight gain is a recognized side effect of cyproterone acetate. It is often caused by fluid retention, hormonal shifts, or changes in metabolic rate and body composition due to reduced androgen levels. Maintaining a balanced diet and regular physical activity can help manage body weight during treatment.